• Published 13 Feb 2019

Bionow Oncology Conference

Focusing upon the strengths in the discovery, development and manufacture of cancer medicines in the North of England through to commercialisation. This event will highlight industry, academic and clinical strengths whilst showcasing key activities, infrastructure and the joined up translational environment which exists in the North.
  • Events

13 Feb 2019    Alderley Park Conference Centre, UK

Focusing upon the strengths in the discovery, development and manufacture of cancer medicines in the North of England through to commercialisation. This event will highlight industry, academic and clinical strengths whilst showcasing key activities, infrastructure and the joined up translational environment which exists in the North.

Resources & Insights

  • 5 Feb 2026
2nd Advances in Translational Drug Development 2026
  • Events
  • 4 Feb 2026
  • Loïc Roux
Make as Insight, Not Execution – Why “Make” Is the Most Misunderstood Step in DMTA
  • Design-Make-Test
  • DMTA
  • Thought Leaders
  • 22 Jan 2026
  • Loïc Roux
Designing Therapeutic Oligonucleotides – A Practical Framework from Biology to Sequence Selection
  • Design-Make-Test
  • DMTA
  • Oligonucleotides
  • Thought Leaders
  • 15 Jan 2026
  • Jordan Fletcher
Peptide Design in Contemporary DMTA Cycles: How DMTA Drives Translational Refinement
  • Design Make Test Analyse
  • DMTA
  • Peptides
  • Thought Leaders